TET2 and peripheral arterial disease: The balance of mutations differed between CS and PAD, with DNMT3A being the most frequently mutated gene (47%) in CS followed by TET2 (36%), while in the PAD cohort, the most common target of mutation was TET2 (55%) followed by DNMT3A (40%).